deltatrials
Recruiting PHASE3 INTERVENTIONAL 3-arm NCT04135664

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Adjuvant Esophagectomy Versus Chemoradiation for Patients With Clinical Stage N0 and Pathological Stage T1b (After Endoscopic Submucosal Dissection, ESD) Esophageal Squamous Cell Carcinoma (Ad-ESD Trial): a Multicentric, Open Label, Randomized Trial

Sponsor: Shanghai Chest Hospital

Conditions Esophageal Cancer
Interventions active surveillance chemoradiation esophagectomy
Updated 4 times since 2019 Last updated: Oct 20, 2019 Started: Sep 1, 2019 Primary completion: Dec 1, 2027 Completion: Dec 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04135664, this PHASE3 trial focuses on Esophageal Cancer and remains actively recruiting participants. Sponsored by Shanghai Chest Hospital, it has been updated 4 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Recruiting PHASE3

  4. Nov 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

    First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Chest Hospital
Data source: Shanghai Chest Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations